Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
Type 2 Diabetes
A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Subjective Cognitive Impairment Associated With Major Adverse CV Events in Patients With T2D
For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.
Genetic Mapping Predicts Risk of Cardiovascular Events in People With Type 2 Diabetes
Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.
Bariatric Surgery Associated With Remission of Prediabetes and Type 2 Diabetes
Investigators assessed outcomes 5 years after bariatric surgery among patients with obesity and type 2 diabetes.
Genetic Risk Scores Predictive of Diabetes Among Youth and Young Adults
A team of investigators used genetic risk scores for type 1 diabetes and type 2 diabetes to identify genetic associations across racial and ethnic groups of youth in the United States.
Genomics-Enhanced Risk Tools and Polygenic Risk Scores for Coronary Heart Disease and T2D
Investigators evaluated the effect of genomics-enhanced, questionnaire-based risk tools on polygenic risk scores for coronary heart disease and type 2 diabetes.
Achieving Treatment Goals in T2D Can Increase Life Expectancy
Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D).
Cognitive Behavioral Therapy for Depression Among Patients With Type 2 Diabetes
Investigators conducted a scoping review of randomized controlled trials that evaluated the impact of cognitive behavioral therapy on symptoms of depression and anxiety among patients with type 2 diabetes.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...